Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Rebamipide SR vs IR in Healthy Volunteers
NCT04150172Phase 1Completed
- Sponsor
- Otsuka Holdings
- Start
- Apr 2019
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rebamipide in gastric ulcer and gastritis (2 arms), sponsored by Otsuka Holdings. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve to the Last Measurable Concentration. Started Apr 2019; status: completed.
02
Drugs
rebamipide
03
Conditions
gastric ulcergastritis
Beyond the preview
Go deeper on NCT04150172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04150172.